Value of tertiary cytoreductive surgery in epithelial ovarian cancer: An international multicenter evaluation

Annals of Surgical Oncology

Volumn 20, Issue 4, 2013, Pages 1348-1354

  Fotopoulou, Christina ^a   Zang, Rongyu ^b   Gultekin, Murat ^c   Cibula, David ^d   Ayhan, Ali ^e   Liu, Dongli ^b   Richter, Rolf ^a   Braicu, Ioana ^a   Mahner, Sven ^f   Harter, Philipp ^g   Trillsch, Fabian ^f   Kumar, Sanjeev ^h   Peiretti, Michele ⁱ   Dowdy, Sean C ^h   Maggioni, Angelo ⁱ   Trope, Claes ^j,k   Sehouli, Jalid ^a  

^a University Hospital   (Germany)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^d CHARLES UNIVERSITY   (Czech Republic)

^e BASKENT UNIVERSITY   (Turkey)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g KLINIKEN ESSEN MITTE   (Germany)

^h MAYO CLINIC   (United States)

ⁱ EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^j OSLO UNIVERSITY HOSPITAL   (Norway)

^k UNIVERSITY OF OSLO   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ASCITES; ASIA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL EVALUATION; CONFERENCE PAPER; CYTOREDUCTIVE SURGERY; DEEP VEIN THROMBOSIS; DISTANT METASTASIS; EUROPE; FEMALE; FOLLOW UP; HUMAN; INTESTINE PERFORATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVARY CARCINOMA; OVERALL SURVIVAL; PANCREAS FISTULA; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE ILEUS; POSTOPERATIVE INFECTION; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; REOPERATION; RETROSPECTIVE STUDY; SEPSIS; SHORT BOWEL SYNDROME; TERTIARY CYTOREDUCTIVE SURGERY; TUMOR RECURRENCE; UNITED STATES;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL AGENCIES; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84875221407     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2673-z     Document Type: Conference Paper

References (21)

1. SJ Chang RE Bristow 2012 Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease Gynecol Oncol. 125 483 492 22366151 10.1016/j.ygyno.2012.02.024
2. DS Chi RE Bristow DK Armstrong BY Karlan 2011 Is the easier way ever the better way? J Clin Oncol. 29 4073 4075 21931018 10.1200/JCO.2011.35.9935 1:CAS:528:DC%2BC3MXhs1CisL%2FK
3. RE Bristow 2000 Surgical standards in the management of ovarian cancer Curr Opin Oncol. 12 474 480 10975556 10.1097/00001622-200009000-00015 1:STN:280:DC%2BD3M%2FmsVWgtQ%3D%3D
4. A du Bois A Reuss E Pujade-Lauraine P Harter I Ray-Coquard J Pfisterer 2009 Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) Cancer. 115 1234 1244 19189349 10.1002/cncr.24149
5. du Bois A, Quinn M, Thigpen T, Vermorken J, Avall-Lundqvist E, Bookman M, et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol. 2005;16:viii7-viii12,2005.
6. DS Chi CC Franklin DA Levine F Akselrod P Sabbatini WR Jarnagin, et al. 2004 Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach Gynecol Oncol. 94 650 654 15350354 10.1016/j.ygyno.2004.01.029
7. DS Chi K McCaughty JP Diaz J Huh S Schwabenbauer AJ Hummer, et al. 2006 Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma Cancer. 106 1933 1939 16572412 10.1002/cncr.21845
8. JO Schorge SN Wingo R Bhore TP Heffernan JS Lea 2010 Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer Int J Gynaecol Obstet. 108 123 127 19892337 10.1016/j.ijgo.2009.08.034
9. F Fanfani A Fagotti V Gallotta A Ercoli F Pacelli B Costantini, et al. 2010 Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery Gynecol Oncol. 116 497 501 20004958 10.1016/j.ygyno.2009. 11.023
10. JY Park JM Eom DY Kim JH Kim YM Kim YT Kim, et al. 2010 Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer J Surg Oncol. 101 418 424 20082350 10.1002/jso.21412
11. P Harter M Hahmann HJ Lueck M Poelcher P Wimberger O Ortmann, et al. 2009 Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis Ann Surg Oncol. 16 1324 1330 19225844 10.1245/s10434-009-0357-0 1:STN:280:DC%2BD1M3lsVSisw%3D%3D
12. N Boran D Hizli S Yilmaz T Turan B Celik E Karabuk, et al. 2012 Secondary cytoreductive surgery outcomes of selected patients with paclitaxel/platinum sensitive recurrent epithelial ovarian cancer J Surg Oncol. 106 369 375 22441998 10.1002/jso.23094
13. MM Leitao Jr S Kardos RR Barakat DS Chi 2004 Tertiary cytoreduction in patients with recurrent ovarian carcinoma Gynecol Oncol. 95 181 188 15385129 10.1016/j.ygyno.2004.07.033
14. AK Karam A Santillan RE Bristow R Giuntoli 2nd GJ Gardner I Cass, et al. 2007 Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome Gynecol Oncol. 104 377 380 17014899 10.1016/j.ygyno.2006.08.037
15. M Gultekin M Velipaşaoǧlu G Aksan P Dursun NU Dogan K Yuce, et al. 2008 A third evaluation of tertiary cytoreduction J Surg Oncol. 98 530 534 18937233 10.1002/jso.21146
16. KK Shih DS Chi RR Barakat MM Leitao Jr 2010 Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series Gynecol Oncol. 117 330 335 20189234 10.1016/j.ygyno.2010.01.046 1:STN:280:DC%2BC3c3jt1yqsg%3D%3D
17. D HIzlI N Boran S YIlmaz T Turan SK AltInbaş B Celik, et al. 2012 Best predictors of survival outcome after tertiary cytoreduction in patients with recurrent platinum-sensitive epithelial ovarian cancer Eur J Obstet Gynecol Reprod Biol. 163 71 75 22480413 10.1016/j.ejogrb.2012.03.018
18. C Fotopoulou R Richter IE Braicu SC Schmidt P Neuhaus W Lichtenegger, et al. 2011 Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer Ann Surg Oncol. 18 49 57 20697821 10.1245/s10434-010-1245-3
19. International Federation of Gynecology and Obstetrics 1987 Changing in definitions of clinical staging for carcinoma of the cervix and ovary Am J Obstet Gynecol. 156 263 264
20. P Harter A du Bois M Hahmann A Hasenburg A Burges S Loibl, et al. 2006 Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial Ann Surg Oncol. 13 1702 1710 17009163 10.1245/s10434-006-9058-0
21. EI Braicu J Sehouli R Richter K Pietzner C Denkert C Fotopoulou 2011 Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers Br J Cancer. 105 1818 1824 22045193 10.1038/bjc.2011.455